Unemployment as a risk factor for AIDS and death for HIV-infected patients in the era of highly active antiretroviral therapy

Sexually Transmitted Infections

Volumn 84, Issue 3, 2008, Pages 183-186

  Delpierre, C ^a,b   Cuzin, L ^c   Lauwers Cances, V ^a   Datta, G D ^b   Berkman, L ^b   Lang, T ^a  

^a INSERM   (France)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SOCIAL ASPECT; UNEMPLOYMENT; AGED; CLINICAL TRIAL; EPIDEMIOLOGY; FRANCE; MIDDLE AGED; MULTICENTER STUDY; STATISTICS;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; EPIDEMIOLOGIC METHODS; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; UNEMPLOYMENT;

EID: 45549097467     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.027961     Document Type: Article

References (19)

1. Wood E, Montaner J, Chan K, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS 2002;16:2065-72.
2. McFarland W, Chen S, Hsu L, et al. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. JAIDS 2003;33:96-103.
3. Rapiti E, Porta D, Forastiere F, et al. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Epidemiology 2000;11:496- 501.
4. Young J, De Geest S, Spirig R, et al. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ 2004;328:15.
5. Dray-spira R, Gueguen A, Persoz A, et al. Temporary employment, absence of stable partnership, and risk of hospitalization or death during the course of HIV infection. JAIDS 2005;40:190-7.
6. Cunningham WE, Hays RD, Duan N, et al. The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. J Health Care Poor Underserved 2005;16:655- 76.
7. Jain S, Schwarcz S, Katz M, et al. Elevated risk of death for African Americans with AIDS, San Francisco, 1996-2002. J Health Care Poor Underserved 2006;17:493-503.
8. Pugliese P, Cuzin L, Enel P, et al. Nadis 2000, développement d'un dossier médical informatisé pour les patients infectés par VIH, VHB et VHC. Presse Med 2003;32:299-303.
9. Delpierre C, Cuzin L, Lauwers-Cances V, et al. High risk groups for late HIV diagnosis of HIV infection: a need for rethinking testing policy in the general population. AIDS Patient Care STDS 2006;20:838-47.
10. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-41.
11. Nadal J, Bourdillon F, Haury B, et al. Les principales caractéristiques de la file active hospitalière des personnes atteintes d'infection à VIH en 1996. Bulletin Epidémiologique Hebdomadaire 1997;23.
12. Chadborn TR, Delpech VC, Sabin CA, et al. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). Aids 2006;20:2371-9.
13. Lert F, Obadia Y. Comment vit-on en France avec le VIH/Sida? Population et sociétés, bulletin de l'INED 2004;406.
14. Delpierre C, Dray-spira R, Cuzin L, et al. Correlates of late diagnosis in France. Implications for testing policy. Int J STD AIDS 2007;18:312-17.
15. Calvez M, Semaille C, Fierro F, et al. Les personnes originaires d'Afrique subsaharienne en accès tardif aux soins pour le VIH: données de l'enquête Retard, France, novembre 2003-août 2004. BEH 2006;31.
16. Lewden C, Jougla E, Alioum A, et al. Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation. Epidemiol Infect 2006;134:1-8.
17. Dray-Spira R, Spire B, Heard I, et al. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study. Aids 2007;21(Suppl 1):S5-12.
18. Carrieri MP, Leport C, Protopopescu C, et al. Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr 2006;41:477-85.
19. Leserman J, Petitto JM, Golden RN, et al. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatry 2000;157:1221-8.